STANGA, Serena
Dettaglio
STANGA, Serena
NEUROSCIENZE "RITA LEVI MONTALCINI"
Pubblicazioni
Risultati 1 - 20 di 27 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Amyloid Precursor Protein (APP) Controls the Expression of the Transcriptional Activator Neuronal PAS Domain Protein 4 (NPAS4) and Synaptic GABA Release | 2020 | Rémi Opsomer, Sabrina Contino, Florian Perrin , Roberta Gualdani , Bernadette Tasiaux , Pierre Doyen, Maxime Vergouts, Céline Vrancx , Anna Doshina, Nathalie Pierrot , Jean-Noël Octave , Philippe Gailly , Serena Stanga , Pascal Kienlen-Campard |
2 | Analysis by a highly sensitive split luciferase assay of the regions involved in APP dimerization and its impact on processing | 2015 | Decock M.; El Haylani L.; Stanga S.; Dewachter I.; Octave J.-N.; Smith S.O.; Constantinescu S.N.; Kienlen-Campard P. |
3 | APP-dependent glial cell line-derived neurotrophic factor gene expression drives neuromuscular junction formation | 2016 | Stanga S.; Zanou N.; Audouard E.; Tasiaux B.; Contino S.; Vandermeulen G.; Rene F.; Loeffler J.-P.; Clotman F.; Gailly P.; Dewachter I.; Octave J.-N.; Kienlen-Campard P. |
4 | BBB damage in aging causes brain iron deposits via astrocyte-neuron crosstalk and Hepc/Fpn1 pathway activation | 2021 | Mezzanotte, Mariarosa; Ammirata, Giorgia; Boido, Marina; Stanga, Serena; Roetto, Antonella |
5 | Brain iron deposits during aging: activation of the Hepc/Fpn1 pathway. | 2021 | Mezzanotte M, Ammirata G, Boido M, Roetto A, Stanga S. |
6 | Cachexia, a Systemic Disease beyond Muscle Atrophy | 2020 | Elisabeth Wyart, Laure B. Bindels, Erica Mina, Alessio Menga, Serena Stanga, Paolo E. Porporato |
7 | Characterization of Pterocarpus erinaceus kino extract and its gamma-secretase inhibitory properties | 2015 | Hage S.; Stanga S.; Marinangeli C.; Octave J.-N.; Dewachter I.; Quetin-Leclercq J.; Kienlen-Campard P. |
8 | Deferasirox-dependent iron chelation enhances mitochondrial dysfunction and restores p53 signaling by stabilization of p53 family members in leukemic cells | 2020 | Chiara Calabrese, Cristina Panuzzo, Serena Stanga, Giacomo Andreani, Silvia Ravera, Alessandro Maglione, Lucrezia Pironi, Jessica Petiti, Muhammad Shahzad Shahzad Ali, Patrizia Scaravaglio, Francesca Napoli, Carmen Fava, Marco De De Gobbi, Francesco Frassoni, Giuseppe Saglio, Enrico Bracco, Barbara Pergolizzi, Daniela Cilloni |
9 | Depressione: le nuove ipotesi sulle basi biologiche e il razionale di impiego e sviluppo dei farmaci antidepressivi | 2008 | Cristina Lanni, Serena Stanga, Adele Lucchelli, Stefano Govoni |
10 | Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment | 2020 | Giovanna Menduti, Daniela Maria Rasà, Serena Stanga, Marina Boido |
11 | The expanding universe of neurotrophic factors: Therapeutic potential in aging and age-associated disorders | 2010 | Lanni C.; Stanga S.; Racchi M.; Govoni S. |
12 | Gamma-secretase inhibitor activity of a pterocarpus erinaceus extract | 2014 | Hage S.; Marinangeli C.; Stanga S.; Octave J.-N.; Quetin-Leclercq J.; Kienlen-Campard P. |
13 | Glycines from the APP GXXXG/GXXXA transmembrane motifs promote formation of pathogenic Aβ oligomers in cells | 2016 | Decock M.; Stanga S.; Octave J.-N.; Dewachter I.; Smith S.O.; Constantinescu S.N.; Kienlen-Campard P. |
14 | Homeodomain interacting protein kinase 2: A target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival | 2010 | Lanni C.; Nardinocchi L.; Puca R.; Stanga S.; Uberti D.; Memo M.; Govoni S.; D'Orazi G.; Racchi M. |
15 | How to Build and to Protect the Neuromuscular Junction: The Role of the Glial Cell Line-Derived Neurotrophic Factor | 2021 | Serena Stanga, Marina Boido, Pascal Kienlen-Campard |
16 | Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe. | 2020 | Cristina Panuzzo, Aleksandar Jovanovski, Barbara Pergolizzi, Lucrezia Pironi, Serena Stanga, Carmen Fava, Daniela Cilloni |
17 | Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases | 2020 | Serena Stanga, Anna Caretto, Marina Boido, Alessandro Vercelli |
18 | “p53 in Alzheimer’s disease: from biomarkers to molecular mechanisms” | 2010 | Serena Stanga |
19 | Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: Focus on p53 | 2008 | Lanni C.; Racchi M.; Uberti D.; Mazzini G.; Stanga S.; Memo M.; Memo E.; Govoni S. |
20 | Presenilin 2-dependent maintenance of mitochondrial oxidative capacity and morphology | 2017 | Contino S, Porporato PE, Bird M, Marinangeli C, Opsomer R, Sonveaux P, Bontemps F, Dewachter I, Octave JN, Bertrand L, Stanga S, Kienlen-Campard P. |